Product Code: GVR-4-68040-449-4
Veterinary Stents Market Growth & Trends:
The global veterinary stents market size is expected to reach USD 56.88 million by 2030, growing at a CAGR of 6.74% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing pipeline products in the market is a crucial factor driving the market over the forecast period.
Various companies across the globe are attempting to enter this niche market by developing novel veterinary stents. For instance, a veterinary medical device startup from New York, the U.S. has multiple veterinary prosthetic devices like artificial valves and stents in the research & development phase. For example, currently, UltraVet Medical Devices Llc. is actively involved in the development of a novel bifurcating bronchial stent. Animals with severe airway disease for whom a conventional straight stent would not be beneficial are the target audience for this Bifurcated Bronchial Stent. In complicated cases, the bifurcated design provides superior treatment than a straight stent given that it addresses both apical (LB1) and posterior (LB2) bronchial collapse and the left stem bronchus.
Furthermore, thorough clinical testing is underway in the veterinary medicine community for employing established stents for veterinary use. For example, in January 2024, AVMA published a clinical study aimed at studying the efficacy of Dumon silicone stents for improving respiratory function in dogs with grade IV tracheal collapse (TC). Dumon silicone stents are manufactured by Boston Medical Products Inc. and are used in human use for airway-stenosis. This study by AVMA revealed that if employed in dogs, these stents prove to be an efficient treatment for TC when they are not responding to medical management.
The market is anticipated to grow due to these developments. These innovative products tackle specific demands, and veterinarians' treatment options will be expanded by the clinical testing of the demonstrated use of certain products in veterinary care. Because of these stents' efficacy in improving respiratory function, their use in veterinary medicine is anticipated to rise. It is anticipated that the growing need for effective treatments for animal respiratory conditions will drive this growth.
Overall, these advancements will support the veterinary stent market's lucrative growth throughout the course of the forecast period. The growing availability of specialty stents made especially for veterinary use will be advantageous to the market. However, one crucial factor that can decline the growth of this market is the volatility of the market players in the recent years. For example, in January 2024, Olympus Corporation announced acquisition of TaeWoong Medical Co. Ltd (parent company of TaeWoong Medical USA). But in just a few months i.e., March 2024, Olympus retracted this deal citing "data integrity issues" with the later.
In similar fashion, Boston Scientific Corporation, a leader in medical devices, announced the acquisition of majority stake in South Korean stent manufacturer, M.I.Tech Co., Ltd in June 2022. However, in May 2023, the former retracted the transaction due to some regulatory approval issues and instead purchased a minority stake in the company. Such volatile activities tend to create an uncertain business environment in the market, potentially hindering its growth.
Veterinary Stents Market Report Highlights:
- Based on product, the airway stents segment held the largest revenue share of 39.06% in 2023. Conditions like stenosis, tracheomalacia, tracheobronchomalacia, and bronchomalacia (airway collapse) lead to respiratory complications in animals. Procedures for correcting them are quite common in veterinary medicine and require stenting to maintain airway patency, driving the demand for the segment.
- Based on animals, the dogs segment dominated the market with a revenue share of 59.19% in 2023. This growth can be attributed to the availability of a large number of products in the market and the high volume of these minimally invasive stenting procedures carried out on dogs.
- Based on application, the vascular obstructions segment is estimated to grow with the highest CAGR of 7.68% over the forecast period due to numerous research activities and innovative techniques being developed for treating vascular obstructions by veterinarians.
- Based on material, the nitinol segment dominated the in terms of revenue share in 2023. This is due to various advantages like elasticity, kink resistance, and biocompatibility which enable this material to conform to complicated structures within the animal's body.
- Based on the end use, the veterinary hospitals & clinics segment dominated the market in 2023 since stenting is a complex and potentially fatal procedure for the animal and these settings have trained personnel as well as required emergency equipment.
- The North America region dominated the market with a revenue share of 49.02% in 2023. This can be owed to the presence of a very well developed veterinary healthcare infrastructure and the presence of leading veterinary stents manufacturers like Dextronix Animal Health, Infiniti Medical, and TaeWoong Medical USA.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Veterinary Stents Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Rapid rise in R&D initiatives
- 3.2.1.2. Increasing Pipeline Products
- 3.2.1.3. Increasing adoption due to proven advantages over other minimally invasive procedures.
- 3.2.1.4. Growing research to explore application of existing products into veterinary use.
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. Associated risk factors
- 3.2.2.2. Market volatility
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Veterinary Stents Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2023
- 3.3.5. Pricing Analysis
- 3.3.6. Pipeline Products Analysis
- 3.3.7. COVID-19 Impact Analysis
Chapter 4. Veterinary Stents Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Veterinary Stents Market Product Movement Analysis
- 4.3. Veterinary Stents Market Size & Trend Analysis, By Product, 2018 - 2030 (USD Million)
- 4.3.1. Airway Stents
- 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.2. Urethral Stents
- 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.3. Vascular Stents
- 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.3.4. Other Stents
- 4.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Veterinary Stents Market: Animal Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Veterinary Stents Market Animal Movement Analysis
- 5.3. Veterinary Stents Market Size & Trend Analysis, By Animal, 2018 - 2030 (USD Million)
- 5.3.1. Dogs
- 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.2. Cats
- 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.3.3. Other Animals
- 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Veterinary Stents Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Veterinary Stents Market Application Movement Analysis
- 6.3. Veterinary Stents Market Size & Trend Analysis, By Application, 2018 - 2030 (USD Million)
- 6.3.1. Airway Collapse
- 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Urinary Tract Obstructions
- 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.3. Vascular Obstructions
- 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.4. Other Applications
- 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Veterinary Stents Market: Material Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Veterinary Stents Market Material Analysis
- 7.3. Veterinary Stents Market Size & Trend Analysis, By Material, 2018 - 2030 (USD Million)
- 7.3.1. Nitinol
- 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Biodegradable Polymer
- 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Veterinary Stents Market: End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Veterinary Stents Market End Use Movement Analysis
- 8.3. Veterinary Stents Market Size & Trend Analysis, By End Use, 2018 - 2030 (USD Million)
- 8.3.1. Veterinary Hospitals & Clinics
- 8.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 8.3.2. Other end-use (academic & research institutions, rescue centers, animal shelters, etc.)
- 8.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 9. Veterinary Stents Market: Country Estimates & Trend Analysis, by product, animal, application, material, & end use
- 9.1. Regional Dashboard
- 9.2. Veterinary Stents Market Share, By Region, 2023 & 2030 (USD Million)
- 9.3. Regional Outlook
- 9.4. North America
- 9.4.1. North America Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.2. U.S.
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Competition Insights
- 9.4.2.3. U.S. Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.3. Canada
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Competition Insights
- 9.4.3.3. Canada Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.4.4. Mexico
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Competition Insights
- 9.4.4.3. Mexico Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5. Europe
- 9.5.1. Europe Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.2. UK
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Competition Insights
- 9.5.2.3. UK Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.3. Germany
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Competition Insights
- 9.5.3.3. Germany Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.4. France
- 9.5.4.1. Key Country Dynamics
- 9.5.4.2. Competition Insights
- 9.5.4.3. France Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.5. Italy
- 9.5.5.1. Key Country Dynamics
- 9.5.5.2. Competition Insights
- 9.5.5.3. Italy Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.6. Spain
- 9.5.6.1. Key Country Dynamics
- 9.5.6.2. Competition Insights
- 9.5.6.3. Spain Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.7. Denmark
- 9.5.7.1. Key Country Dynamics
- 9.5.7.2. Competition Insights
- 9.5.7.3. Denmark Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.8. Sweden
- 9.5.8.1. Key Country Dynamics
- 9.5.8.2. Competition Insights
- 9.5.8.3. Sweden Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.5.9. Norway
- 9.5.9.1. Key Country Dynamics
- 9.5.9.2. Competition Insights
- 9.5.9.3. Norway Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6. Asia Pacific
- 9.6.1. Asia Pacific Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.2. Japan
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Competition Insights
- 9.6.2.3. Japan Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.3. China
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Competition Insights
- 9.6.3.3. China Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.4. India
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Competition Insights
- 9.6.4.3. India Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.5. Australia
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Competition Insights
- 9.6.5.3. Australia Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.6. South Korea
- 9.6.6.1. Key Country Dynamics
- 9.6.6.2. Competition Insights
- 9.6.6.3. South Korea Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.6.7. Thailand
- 9.6.7.1. Key Country Dynamics
- 9.6.7.2. Competition Insights
- 9.6.7.3. Thailand Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7. Latin America
- 9.7.1. Latin America Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.7.2. Brazil
- 9.7.2.1. Key Country Dynamics
- 9.7.2.2. Competition Insights
- 9.7.2.3. Brazil Veterinary Stents Market Estimates And Forecasts, 2018 - 2030
- 9.7.3. Argentina
- 9.7.3.1. Key Country Dynamics
- 9.7.3.2. Competition Insights
- 9.7.3.3. Argentina Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8. Middle East & Africa
- 9.8.1. Middle East & Africa Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.2. South Africa
- 9.8.2.1. Key Country Dynamics
- 9.8.2.2. Competition Insights
- 9.8.2.3. South Africa Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.3. Saudi Arabia
- 9.8.3.1. Key Country Dynamics
- 9.8.3.2. Competition Insights
- 9.8.3.3. Saudi Arabia Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.4. UAE
- 9.8.4.1. Key Country Dynamics
- 9.8.4.2. Competition Insights
- 9.8.4.3. UAE Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 9.8.5. Kuwait
- 9.8.5.1. Key Country Dynamics
- 9.8.5.2. Competition Insights
- 9.8.5.3. Kuwait Veterinary Stents Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Competitive Landscape
- 10.1. Market Participant Categorization
- 10.2. Participants Overview
- 10.3. Financial Performance
- 10.4. Product Benchmarking
- 10.5. Market Position Analysis, 2023 (Heat Map Analysis)
- 10.6. Strategy Mapping
- 10.6.1. MERGERS AND ACQUISITIONS
- 10.6.2. LAUNCH
- 10.6.3. PARTNERSHIPS & COLLABORATIONS
- 10.6.4. EXPANSION
- 10.6.5. OTHERS
- 10.7. Company Profiles
- 10.7.1. Dextronix Animal Health
- 10.7.1.1. Participant's overview
- 10.7.1.2. Financial performance
- 10.7.1.3. Product benchmarking
- 10.7.1.4. Strategic initiatives
- 10.7.2. Infiniti Medical
- 10.7.2.1. Participant's overview
- 10.7.2.2. Financial performance
- 10.7.2.3. Product benchmarking
- 10.7.2.4. Strategic initiatives
- 10.7.3. TaeWoong Medical USA
- 10.7.3.1. Participant's overview
- 10.7.3.2. Financial performance
- 10.7.3.3. Product benchmarking
- 10.7.3.4. Strategic initiatives
- 10.7.4. Create Medic Co. Ltd.
- 10.7.4.1. Participant's overview
- 10.7.4.2. Financial performance
- 10.7.4.3. Product benchmarking
- 10.7.4.4. Strategic initiatives
- 10.7.5. AbtVet (Stening Group)
- 10.7.5.1. Participant's overview
- 10.7.5.2. Financial performance
- 10.7.5.3. Product benchmarking
- 10.7.5.4. Strategic initiatives
- 10.7.6. M.I. Tech Co. Ltd
- 10.7.6.1. Participant's overview
- 10.7.6.2. Financial performance
- 10.7.6.3. Product benchmarking
- 10.7.6.4. Strategic initiatives
- 10.7.7. UltraVet Medical Devices LLC.
- 10.7.7.1. Participant's overview
- 10.7.7.2. Financial performance
- 10.7.7.3. Product benchmarking
- 10.7.7.4. Strategic initiatives
- 10.8. List of Leading Institutions providing stenting procedures, by key countries
Chapter 11. Key Takeaways